1. Antibody Response to Polysaccharide Conjugate Vaccines after Nonmyeloablative Allogeneic Stem Cell Transplantation 
Aafke Meerveld-Eggink, Ankie M.T. van der Velden, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Douwe H. Biesma, Ger T. Rijkers 
Biology of Blood and Marrow Transplantation 
Volume 15, Issue 12, Pages (December 2009)
DOI: /j.bbmt
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) Geometric mean titers before and after Hib and pneumococcal vaccination. Geometric mean titers (in μg/mL) with 95% confidence interval prevaccination (gray columns) and postvaccination (black columns). (B) Geometric mean titers before and after tetanus vaccination. Geometric mean titers (in IU/mL) with 95% confidence interval prevaccination (gray column) and postvaccination (black column).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
(A) Percentage of patients with pneumococcal serotype-specific IgG concentrations ≥0.35μg/mL pre- and postvaccination. Percentage of patients with pneumococcal serotype-specific IgG concentrations ≥0.35μg/mL before (gray columns) and after (black columns) vaccination. (B). Percentage of patients with pneumococcal serotype-specific IgG concentrations ≥1.0μg/mL pre- and postvaccination. Percentage of patients with pneumococcal serotype-specific IgG concentrations ≥1.00μg/mL before (gray columns) and after (black columns) vaccination.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Percentage of patients with anti-Hib IgG concentrations ≥1.0 μg/mL pre- and postvaccination. Percentage of patients with anti-Hib IgG concentrations ≥1.0 μg/mL before (gray column) and after (black column) vaccination.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
Percentage of patients with antitetanus toxoid IgG concentrations ≥0.1 IU/mL pre- and postvaccination. Percentage of patients with antitetanus toxoid IgG concentrations ≥0.1 IU/mL before (gray column) and after (black column) vaccination.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions